Shoko Matsui

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Journal: Rheumatology (Oxford, England)

Published: April 24, 2026

Unexpected decline of pulmonary function in a patient with thymoma mimicking obstructive bronchiolitis.

Unexpected decline of pulmonary function in a patient with thymoma mimicking obstructive bronchiolitis.

Journal: Respiratory investigation

Published: March 17, 2026

IgG4-related disease in the Japanese population: a whole-genome sequencing study.

IgG4-related disease in the Japanese population: a whole-genome sequencing study.

Journal: The Lancet. Rheumatology

Published: March 30, 2025

Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.

Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.

Journal: Immunological medicine

Published: November 28, 2024

Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio.

Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio.

Journal: In vivo (Athens, Greece)

Published: October 23, 2024

Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.

Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.

Journal: Molecular and clinical oncology

Published: January 13, 2024

An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.

An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.

Journal: Discover oncology

Published: November 30, 2023

Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.

Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.

Journal: Anticancer research

Published: October 05, 2023

Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in Japan.

Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in Japan.

Journal: Kidney international reports

Published: June 28, 2023

Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors.

Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors.

Journal: Anticancer research

Published: April 13, 2023

The 2022 revised diagnostic criteria for IgG4-related respiratory diseases.

The 2022 revised diagnostic criteria for IgG4-related respiratory diseases.

Journal: Respiratory investigation

Published: April 01, 2023

Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.

Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.

Journal: Thoracic cancer

Published: March 15, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026